How Will the Duchenne Muscular Dystrophy Market Grow? Key Trends and Opportunities for 2025 and Beyond
Updated 2025 Market Reports Released: Trends, Forecasts to 2034 – Early Purchase Your Competitive Edge Today!
How has the duchenne muscular dystrophy market grown in recent years?
The market size for Duchenne muscular dystrophy has experienced significant growth in the past few years. The sector, which is expected to increase from $1.16 billion in 2024 to $1.26 billion in 2025, boasts a compound annual growth rate (CAGR) of 8.9%. This growth during the historic period is linked to improvements in genetic research and diagnostics, advancements in clinical trials, heightened patient advocacy and awareness, the designation and incentives of orphan drugs, and joint research initiatives.
How is the duchenne muscular dystrophy market size expected to evolve during the forecast period?
Get your duchenne muscular dystrophy market report here!
https://www.thebusinessresearchcompany.com/report/duchenne-muscular-dystrophy-global-market-report
Which key drivers are propelling the duchenne muscular dystrophy market’s growth?
The rise in chronic diseases is likely to fuel the expansion of the Duchenne muscular dystrophy market in the coming years. A chronic disease is defined as a health concern or situation with enduring symptoms that last for a minimum of a year. Duchenne muscular dystrophy plays a significant role in the occurrence of chronic diseases due to its emphasis on the unique therapeutic needs of individuals carrying this genetic anomaly, thereby underlining the wider importance of personalized medicine in controlling and possibly reducing the effects of chronic diseases. For instance, the National Library of Medicine, a US governmental entity, reported in January 2023 that by 2050, the number of Americans aged 50 and older with at least one chronic condition is expected to rise to 142.66 million. Thus, the escalating prevalence of chronic diseases is a key driver for the growth of the Duchenne muscular dystrophy market.
What are the market segments in the duchenne muscular dystrophy industry?
The duchenne muscular dystrophy market covered in this report is segmented –
1) By Therapy: Mutation Suppression, Exon Skipping Approach
2) By Therapeutic Class: Molecular Based Therapies, Steroid Therapy
3) By Route Of Administration: Oral, Parenteral, Other Routes Of Administration
4) By Distribution Channel: Hospital Pharmacy, Online Pharmacy, Retail Pharmacy
5) By End User: Hospitals, Homecare, Specialty Clinics, Other End-Users
Subsegments:
1) By Mutation Suppression: Antisense Oligonucleotides (ASOs), Small Molecules, Gene Therapy
2) By Exon Skipping Approach: Exon-Skipping Therapies, Combination Therapies, Clinical Trials And Investigational Drugs
Get your free sample now – explore exclusive market insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=10368&type=smp
Which leading companies are shaping the growth of the duchenne muscular dystrophy market?
Major companies operating in the duchenne muscular dystrophy market include Pfizer Inc., GlaxoSmithKline plc, PerkinElmer Inc., BioMarin Pharmaceutical Inc., Sarepta Therapeutics Inc., PTC Therapeutics Inc., Asklepios BioPharmaceutical Inc., Catabasis Pharmaceuticals Inc., Wave Life Sciences Ltd., Bristol Myers Squibb Company, BridgeBio Pharma Inc., Rocket Pharmaceuticals Inc., Italfarmaco SpA, Solid Biosciences Inc., Avidity Biosciences Inc., Fulcrum Therapeutics Inc., Akashi Therapeutics Inc., WAVE Life Sciences Ltd., Capricor Therapeutics Inc., Santhera Pharmaceuticals Holding, Armagen Technologies Inc., Dyne Therapeutics Inc., Benitec Biopharma Limited, Edgewise Therapeutics Inc.
What key trends are currently impacting the duchenne muscular dystrophy market’s development?
Leading organizations within the Duchenne muscular dystrophy market are implementing technological advancements like clinical trial design to increase the efficacy and speed of drug development processes, better patient results, and hasten the authorization of new treatments. The clinical trial design is a method of arranging and preparing a clinical trial to determine the safety and efficacy of a new treatment, which includes establishing goals, choosing participants and defining procedures and evaluations. For example, in March 2024, the non-profit organization based in the US, Critical Path Institute (C-Path), unveiled the DMD Clinical Trial Simulator (CTS). This resourceful instrument, conceived by the Duchenne Regulatory Science Consortium of C-Path, intends to enhance the design of efficacy studies for DMD treatments. The CTS, available to the public through the C-Path website and the Rare Disease Cures Accelerator-Data and Analytics Platform (RDCA-DAP), offers features like advanced functional test performance modeling, the ability to emulate different circumstances, improved efficiency in trial design and proves as an invaluable asset for researchers and pharmaceutical corporations involved in DMD research.
Unlock exclusive market insights – purchase your research report now for a swift delivery!
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=10368
Which geographic areas are influencing the growth of the duchenne muscular dystrophy market?
North America was the largest region in the Duchenne muscular dystrophy market in 2024. Asia-Pacific is expected to be the fastest-growing region in the global duchenne muscular dystrophy market during the forecast period. The regions covered in the duchenne muscular dystrophy market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Browse Through More Similar Reports By The Business Research Company:
Connected Healthcare Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/connected-healthcare-global-market-report
Generic Musculoskeletal Disorders Drugs Global Market Report 2024
Pharmacies and Healthcare Stores Global Market Report 2024
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Contact us at:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at [email protected]
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Found this article helpful? Share it on:
